Celularity, Inc. (CELU)
NASDAQ: CELU · IEX Real-Time Price · USD
6.07 -0.22 (-3.50%)
Dec 3, 2021 4:00 PM EST - Market closed
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
| Year | 2020 | 2019 |
|---|---|---|
| Revenue | 14.28 | 21.15 |
| Revenue Growth | -32.48% | - |
| Cost of Revenue | 4.93 | 6.32 |
| Gross Profit | 9.35 | 14.82 |
| Selling, General & Admin | 31.34 | 41.79 |
| Research & Development | 52.71 | 46.05 |
| Other Operating Expenses | 132.79 | 122.24 |
| Operating Expenses | 216.84 | 210.09 |
| Operating Income | -207.49 | -195.26 |
| Interest Expense / Income | 2.35 | 0 |
| Other Expense / Income | 3.09 | 72.73 |
| Pretax Income | -212.93 | -267.99 |
| Income Tax | -4.7 | -56.11 |
| Net Income | -208.23 | -211.88 |
| Net Income Common | -208.23 | -211.88 |
| Shares Outstanding (Basic) | 24 | 24 |
| Shares Outstanding (Diluted) | 24 | 24 |
| Shares Change | 0.38% | - |
| EPS (Basic) | -8.69 | -8.88 |
| EPS (Diluted) | -8.69 | -8.88 |
| Free Cash Flow Per Share | -3.80 | -4.12 |
| Gross Margin | 65.46% | 70.10% |
| Operating Margin | -1453.22% | -923.36% |
| Profit Margin | -1458.42% | -1001.94% |
| Free Cash Flow Margin | -637.53% | -464.69% |
| Effective Tax Rate | 2.21% | 20.94% |
| EBITDA | -202.41 | -261.81 |
| EBITDA Margin | -1417.60% | -1238.04% |
| EBIT | -210.58 | -267.99 |
| EBIT Margin | -1474.85% | -1267.29% |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).